He arrived at Christiana Hospital in DE in the early afternoon for his jab, and said: "My number one priority is getting vaccine in people's arms, like we just did today, as rapidly as we can".
The Trump administration is asking states to speed delivery of COVID-19 vaccines to people 65 and older and to others at high risk by no longer holding back the second dose of the two-dose shots, officials said Tuesday.
Last week, a spokesman for President-elect Joe Biden said Biden, who takes office January 20, would release more of the reserved doses.More news: Sonic boom as fighter jets intercept private plane
The administration is also urging states to expand vaccination to more venues, such as convention center "mega-sites", pharmacies and community health centers. He said he supported immediately releasing vaccines that health authorities were holding back out of caution, to guarantee they would be available for people needing their second dose. "We are working on that program now", he said.
Azar said they'll brief the Biden transition team on the changes, but didn't seek their blessing. Now, officials say they are confident the needed supply will be there.
While the decision for who is eligible to get a vaccine is up to states, recommendations from the federal government are influential. Then between June and September, the plan is to vaccinate almost 20 million more people, seeing Canada hitting and surpassing the herd immunity threshold.
"By opening things up... there would be some gains in efficiency, but there would be significant losses as it relates to equity, racial justice, and the ability to ... prevent morbidity and mortality in a high-risk group", said Kristen Ehresmann, director of infectious disease epidemiology, prevention, and control for the Minnesota Department of Health.More news: Britain expected to ban China imports linked to Uighur camps
Moderna also informed the markets today about its financial status, saying it expects company cash, cash equivalents, and investments as of December 31, 2020 to be around US$5.25bn (unaudited), as compared to $1.26bn on that date the year prior.
"We hope to have that information very soon", Johnson & Johnson CEO Alex Gorsky said Monday at J.P. Morgan's annual health care conference. "The quicker everyone gets vaccinated, the quicker we're going to be able to get back to a semblance of normality", he said.
"Unlike mRNA vaccines, which use messenger RNA to create a protein that prompts an immune response in the body, our investigational COVID-19 vaccine uses an adenovirus - a type of virus that causes the common cold - that has been made unable to replicate", Mammen said in the online statement.
Some states, including Arizona, have or are planning to open up mass vaccination centers, aiming to inoculate thousands of people a day in a single location.More news: NBA Reviewing Alleged Videos Of Kyrie Irving Partying Without A Mask